{"name":"Innovation Pharmaceuticals, Inc.","slug":"innovation-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Kevetrin","genericName":"Kevetrin","slug":"kevetrin","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Kevetrin","genericName":"Kevetrin","slug":"kevetrin","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOVFR2WlNIbWMxR0ZOSV9xZjBWTW5GNEJkTTBvSEVXMjM0MkhDRWpqZms1TWNzc2lReGtONUtIaEdMZTZaNUdxcjhUUWZCNzM1UkhfMF83OC1RV0FEVXY2eEUyVUxSN1p5OUZoQ244enFFNnpMb2gxMVphWU8wa3ZBbEdaRDNsNXlrS01GQ2xLZnpLdVQyYW1ZS2gxR3ZGbXVwUTBDNWNHUEZOaG1xQ1pBY3Q2VQ?oc=5","date":"2026-03-26","type":"pipeline","source":"Yahoo Finance","summary":"SK pharmteco to Host Innovations in Pharmaceutical Manufacturing Symposium in Cambridge, Massachusetts - Yahoo Finance","headline":"SK pharmteco to Host Innovations in Pharmaceutical Manufacturing Symposium in Cambridge, Massachusetts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPMldZTmZfWnZES19TSHlnb3lUS2wyMDhXNWUyamlxbzhFbE10U0lmYVhaVHhscFUzbE0zWW5FRm9ycEYzVHJqZnJmZThCRC1zekxnWExXTG5wVnQ0aFhUZDRuYmtVZDdnclQ3TG1SUV9qMHU5OC1RTDlHWUx3dlBiM1hRM2NiMGRVU0ZYRFFfWjVGVGlCMmc?oc=5","date":"2026-03-25","type":"pipeline","source":"Britannica","summary":"Pharmaceutical industry - Drug Discovery, Research, Innovation - Britannica","headline":"Pharmaceutical industry - Drug Discovery, Research, Innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFExZC0tNU1iT09JQWdGRXZVTWszUkpFbGJfNDJ6RG1xelFmdF95Q1g0U0tkR1pqdkNXVHdTYlFKS2VGV3NVWlRHaVpMa3VIaXUzZGN4Wl9DMWR2Z3cyN09mVGREMmxjU0NZYlAxajE4WlJ1WFlMMEhKWWRyRmtUWm51RVVsWXNaVld3bkt2TzBDaUZCTjF6cElxZTJNVFlTTkRwUkY4MUpQUQ?oc=5","date":"2026-03-24","type":"pipeline","source":"Fast Company","summary":"The most innovative medicine, therapeutics, and pharmaceutical companies of 2026 - Fast Company","headline":"The most innovative medicine, therapeutics, and pharmaceutical companies of 2026","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-20","type":"regulatory","source":"PR Newswire","summary":"Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical Entity Opening New Horizons in Psychiatric Innovatio","headline":"Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Sch","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNdkstZTJXZVFmdWZTV1FLbXhtVThWTjRsS1pqd0JqN3JUQTdHZDFGOFhrNTZIQ0hiMHF6cXpyWUVieEF5eWhhYm5VUzBEemstdDg2dEtETnE1bEN1LTVfM2lRdWZzY2MzaHVUMzZjX2h5SXNDaTBwaURYbVBKWkRhYS1qczNWcFZ6cVY2NEdudVhoM1NiVUJ0OU1n?oc=5","date":"2026-02-02","type":"pipeline","source":"Bain & Company","summary":"Accelerating Growth and Innovation in European Mid-Sized Pharma - Bain & Company","headline":"Accelerating Growth and Innovation in European Mid-Sized Pharma - Bain & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE04UTlJYjBMZ09keXEwQ2tnNmwzLTh4ejlNZ1d6bjByV1lIVzV1QXpid1FyWk5oTnoxQ2k2TzhNSE9TeXBoVFF3VTJnQS1RWjhIbUhicV9RN0xETVZja3EtQjJn?oc=5","date":"2026-01-29","type":"pipeline","source":"康方生物","summary":"Ivonescimab Included in FirstWord Pharma's \"The Drugs That Will Shape 2026\" - 康方生物","headline":"Ivonescimab Included in FirstWord Pharma's \"The Drugs That Will Shape 2026\" - 康方生物","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNMzNBZ1BCVzdmUnFMeHZDTWVCSGtTUzA0aUhXQ3RjaU9WWUEyY09PNjBrcHktME5vRUx2dmlieFBtLW1Cb2NJN09OZEY2VXZkUUx4OWdKVGwwOVdkbjBhT2hGMzF1T3B0Q1B3eFdaejVyVjBKNFVHNGpGUnlQU2RlNTE3UnRBOFN5cnNjN3F3?oc=5","date":"2026-01-05","type":"pipeline","source":"Pharma Voice","summary":"3 of China’s most innovative pharma companies - Pharma Voice","headline":"3 of China’s most innovative pharma companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxQeVNuaEhMRktWZUUyWWpUTnhuMkRPNDZuQ2dLZFp1NlA2cG1UT2hTemd2SF9GQ3RGMVQxZWdOeG1Ubk1HdlY3U3ZEb1ZMaW1jd2NpOXk0T2dFYmFuNGlzQkxhZHVqeWNOQm5NN3FHZTFjUVR2VENpRVZZMEdQVEMtMktKcXJrVTMydUNJSkVKQ2RKNWs1bG5keXZLQ3RTd0NlRk5rOHFWd1FENERjWm1HZXViOEROUmpnVFBsZWpfcGg3N1hMYUVKVWN0X1pwRW5LS0x6bXhvZ0FpeTllOW5kcC1sOHJVTGR5VFExWG9CelJKSTU2V21XZjI4QQ?oc=5","date":"2025-10-23","type":"earnings","source":"GlobeNewswire","summary":"Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 - GlobeNewswire","headline":"Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxOeDkyLVJfS1Q2THB1c1Vaa1d0TU1YdVB3YUdvRXI4c2lscWtNbGhVaEEtMEo3SUd6MUZMdzNHTVUydVNUampOTGRlWVBPeTBKaC1KT0Y1X2hpUUczV0lNOVdpUjFaSDVKd1cxSm9TOGxxWEd5ZlVRV0p5TUN1U2k5dmpDTTNjdkFUX3Vjc3Z6Wk4tRkxITGlXcEJlZmR6TnF2QnlMQW5CNlBGRmJMbjVjaHF4VkdSWGRHOV9KeDF0dTF0N01kczVQb2ZNSGl4LWY5MTN1a2sycFlsVi1JbnFma21nSHA2ZllFVC1oV1VUeDhicGtNNmdBZG5DRWZ6b3N3Z2tBTi1tSFViUXlsWTZTcm5DRXdPdVJf?oc=5","date":"2025-09-23","type":"trial","source":"The Conversation","summary":"Some new drugs aren’t actually ‘new’ – pharmaceutical companies exploit patents and raise prices for patients, but data transparency can help protect innovation - The Conversation","headline":"Some new drugs aren’t actually ‘new’ – pharmaceutical companies exploit patents and raise prices for patients, but data ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPQm5Bb2ZDM2VWb0hRY3VGOWFSekdBV25HVUhFVk83YzBsZlQ2VHl4T1NKS1RpcjR4T2dDUl9rOXBwaTZ6dkZJSWkzUmZTZjZNVEdwRDZOWlBLU1BQdmJzSEVkb2V4emFVTGwyUFIxOEV2emwyQUN5SlBSQ01HRVBReTRwdzR1dm5oZUZQQTNFQ3dBcGJfX1ZpV2hZYlpkdFhWZG5MSm5jV1RhcS1KVUNXRExXYXQ1SkdWX2gzbi0wMDZEZTA?oc=5","date":"2025-07-13","type":"pipeline","source":"Bloomberg.com","summary":"China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline - Bloomberg.com","headline":"China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNWGxIQThZakc3VWloSkRXVzlQR3ZWRUpBeHFGNXZCTGRJaEZxMDJzVHRUUDF5dW9rWFVFQnhzUmdZRXYycXMwTWRrNi04Nl9qTlp0NzZqMTRVMldVbjJVUHQwTXlFMGFVNTRuS2NKS0tyR2MzZDBScWVJZTdNNlJwWmNJOGtjd01LRm9KMmxTSDdlZkt5bXJVblB6ZURZVDdCTmNsd096cmxyaE5FV2JVU0EzSUZmb1dFZ2JlSW5YTHZKTFV6bWtwbA?oc=5","date":"2025-06-18","type":"pipeline","source":"Deloitte","summary":"Measuring the return from pharmaceutical innovation 2024 - Deloitte","headline":"Measuring the return from pharmaceutical innovation 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxNcUttZGx5Q25BdUs4eUtCMXEyci1vQlIwMEtQeHk1UTlGRFdMUkViRjJzeXpKNEV4SVhOekNNbVhBMGpYM0FhQjVTMXRlMXczOHd4cWJSQ2JhVklZeUlic092eExsS3JZdDhCaGFFbmlXRy1ZMG42cjN0czVQTzlmMDVJT1ljaXFVWjVTYjlFRWUwSDBCYnhCNVgxSFpoaE1IZXo2R1R5NG1zUDduWU8wbk9Gcko4amx3YTVyMXA5MFVkeGphSEpRQ1R4aFl3SHhJT3ZIaVBRVHQtb1l1eXBBZm5BSmpIb2lYdTJNel91bVRNSmhQSXlwVXFkdDZsZ0N2dzVaaWh2RWVIclVqSFI1bzZHczFZZ2ZVaVl4Rzh5S0c1eHR5TkJyc2ZJNkptZ0xQVnlGWlFCQ3Y?oc=5","date":"2025-06-04","type":"deal","source":"BioSpace","summary":"Buscar Company Acquires 70% Stake in Armorgenix, Bolstering Portfolio with Pharmaceutical Innovation and Positioning for Growth in the U.S. Antiviral and Detoxification Markets - BioSpace","headline":"Buscar Company Acquires 70% Stake in Armorgenix, Bolstering Portfolio with Pharmaceutical Innovation and Positioning for","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}